Correlation Between Benitec Biopharma and XTL Biopharmaceutica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Benitec Biopharma and XTL Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Benitec Biopharma and XTL Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Benitec Biopharma Ltd and XTL Biopharmaceuticals Ltd, you can compare the effects of market volatilities on Benitec Biopharma and XTL Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Benitec Biopharma with a short position of XTL Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Benitec Biopharma and XTL Biopharmaceutica.

Diversification Opportunities for Benitec Biopharma and XTL Biopharmaceutica

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Benitec and XTL is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Benitec Biopharma Ltd and XTL Biopharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTL Biopharmaceuticals and Benitec Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Benitec Biopharma Ltd are associated (or correlated) with XTL Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTL Biopharmaceuticals has no effect on the direction of Benitec Biopharma i.e., Benitec Biopharma and XTL Biopharmaceutica go up and down completely randomly.

Pair Corralation between Benitec Biopharma and XTL Biopharmaceutica

Given the investment horizon of 90 days Benitec Biopharma Ltd is expected to generate 0.91 times more return on investment than XTL Biopharmaceutica. However, Benitec Biopharma Ltd is 1.1 times less risky than XTL Biopharmaceutica. It trades about 0.07 of its potential returns per unit of risk. XTL Biopharmaceuticals Ltd is currently generating about 0.04 per unit of risk. If you would invest  318.00  in Benitec Biopharma Ltd on September 27, 2024 and sell it today you would earn a total of  882.00  from holding Benitec Biopharma Ltd or generate 277.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.19%
ValuesDaily Returns

Benitec Biopharma Ltd  vs.  XTL Biopharmaceuticals Ltd

 Performance 
       Timeline  
Benitec Biopharma 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Benitec Biopharma Ltd are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Benitec Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.
XTL Biopharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days XTL Biopharmaceuticals Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Benitec Biopharma and XTL Biopharmaceutica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Benitec Biopharma and XTL Biopharmaceutica

The main advantage of trading using opposite Benitec Biopharma and XTL Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Benitec Biopharma position performs unexpectedly, XTL Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTL Biopharmaceutica will offset losses from the drop in XTL Biopharmaceutica's long position.
The idea behind Benitec Biopharma Ltd and XTL Biopharmaceuticals Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
CEOs Directory
Screen CEOs from public companies around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation